UDK: 543.544.32:615.453.66
A. V. Tolkacheva, L. N. Grushevskaya, N. I. Avdyunina, B. M. Pyatin, L. M. Gaevaya, A. S. Miheeva, V. I. Prokofeva, E. V. Blinskaya
Научно-исследовательский институт фармакологии им. В. В. Закусова, Москва, Первый Московский государственный медицинский университет им. И. М. Сеченова
The objective of this study was to develop and to validate a new assay of the active ingredient in Kemantane tablets by GC-FID. Chromatographic separation was performed on the fused silica capillary column - W COT Fused Silica CP-WAX 52 CB: 50 m, 0,32mm, 1,2 m. Parameters of the chromatographic system suitability and robustness of the technique were determined. The developed technique was validated; several serial samples of Kemantane tablets 100 mg were analyzed.
kemantane, tablets, 5-hydroxyadamantan-2-one, assay, validation, gas liquid chromatography, GLC.
Толкачева Анна Валентиновна — м. н. с. ОТО ФГБУ «НИИ фармакологии имени В. В. Закусова», аспирант кафедры фармацевтической и токсикологической химии ГБОУ ВПО Первый МГМУ им. И. М. Сеченова, e-mail: av-tolkacheva@rambler.ru